Monoclonal Antibodies (mAbs): The Evolution of mAbs

Author(s): Munro Nancy L

Contact Hours 1.10

CERP A 1.10

Expires Dec 31, 2026

Topics: Medication Management

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Immunomodulation is the adjustment of the immune system response using substances that activate or depress its function. As a result of this manipulation, an antigen-antibody reaction occurs, triggering an inflammatory response involving cytokines that hopefully will destroy the disease process target. Monoclonal antibodies were developed to trigger this immune reaction which may cause a cytokine storm, resulting in significant clinical deterioration that requires critical care interventions.

Objectives

  • Explore the role of monoclonal antibodies in immunomodulation.
  • Identify the scientific rationale(s) for selecting a ‘drug of choice’ selection, including evidence-based guidelines.
  • Analyze the mechanism of action and the side effects of mAb and their associated treatments.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.